High number of CD56bright NK-cells and persistently low CD4+ T-cells in a hemophiliac HIV/HCV co-infected patient without opportunistic infections

Virology Journal

Volumn 10, Issue 1, 2013, Pages

  Fregni, Giulia ^a,b,g   Freire Maresca, Anaenza ^c   Jalbert, Valérie ^c   Caignard, Anne ^a,b   Scott Algara, Daniel ^f   Bordé Cramer, Elisabeth ^a,b,c,d   Rouveix, Elisabeth ^c,d   Béné, Marie C ^e   Capron, Claude ^a,b,c,d  

^a INSTITUT COCHIN   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔPITAL AMBROISE PARÉ   (France)

^d LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^e HÔTEL DIEU   (France)

^f INSTITUT PASTEUR   (France)

^g UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

CD4; HCV; HIV; NK cells; Opportunistic infections

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIRETROVIRUS AGENT; ASPARTATE AMINOTRANSFERASE; CD158B ANTIGEN; CD16 ANTIGEN; CD56 ANTIGEN; CD57 ANTIGEN; CD69 ANTIGEN; CELL RECEPTOR; GAMMA GLUTAMYLTRANSFERASE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; INTERLEUKIN 5; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL1; LYMPHOCYTE ANTIGEN; NATURAL CYTOTOXICITY RECEPTOR; NATURAL CYTOTOXICITY RECEPTOR 2; NATURAL KILLER CELL RECEPTOR NKG2D; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ZIDOVUDINE; NCAM1 PROTEIN, HUMAN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; BLOOD LEVEL; CASE REPORT; CD4+ T LYMPHOCYTE; CLINICAL FEATURE; CYTOKINE PRODUCTION; CYTOLYSIS; DEGRANULATION; DISEASE ASSOCIATION; FLOW CYTOMETRY; HEMOPHILIA; HEPATITIS C; HEPATITIS C VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MALE; MEDICAL HISTORY; MIXED INFECTION; MOLECULAR DYNAMICS; NATURAL KILLER CELL; OPPORTUNISTIC INFECTION; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PATIENT COMPLIANCE; TH1 CELL; TH2 CELL; VIRUS IDENTIFICATION; VIRUS LOAD; CD4 LYMPHOCYTE COUNT; CHEMISTRY; HEMOPHILIA A; IMMUNOLOGY;

HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS;

ADULT; ANTIGENS, CD56; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CELL DEGRANULATION; HEMOPHILIA A; HEPATITIS C; HIV INFECTIONS; HUMANS; KILLER CELLS, NATURAL; MALE; VIRAL LOAD;

MLCS; MLOWN;

EID: 84872796535     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-10-33     Document Type: Article

References (32)

1. Piketty C, Castiel P, Belec L, Batisse D, Si Mohamed A, Gilquin J, et al: Discrepant responses to triple combination antiretroviral therapy in advanced HIV disease. AIDS 1998, 12:745-750.
2. Ragni MV, Moore CG, Soadwa K, Nalesnik MA, Zajko AB, Cortese-Hassett A, et al: Impact of HIV on liver fibrosis in men with hepatitis C infection and haemophilia. Haemophilia 2011, 17:103-111.
3. Koziel MJ, Peters MG: Viral hepatitis in HIV infection. N Eng J Med 2007, 356:1445-1454.
4. Monforte A, Abrams D, Pradier C, Weber R, Reiss P, Bonnet F, et al: HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies. AIDS 2008, 22:2143-2153.
5. Krämer B, Körner C, Kebschull M, Glässner A, Eisenhardt M, Nischalke HD, et al: NKp46(High) expression defines a NK cell subset that is potentially involved in control of HCV replication and modulation of liver fibrosis. Hepatology 2012, 56(4):1201-1213.
6. Alter G, Malenfant JM, Delabre RM, Burgett NC, Yu XG, Lichterfeld M, et al: Increased natural killer cell activity in viremic HIV-1 infection. J Immunol 2004, 173:5305-5311.
7. Alter G, Malenfant JM, Altfeld M: CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods 2004, 294:15-22.
8. Aktas E, Kucuksezer UC, Bilgic S, Erten G, Deniz G: Relationship between CD107a expression and cytotoxic activity. Cell Immunol 2009, 254:149-154.
9. Nagler A, Lanier LL, Cwirla S, Phillips JH: Comparative studies of human FcRIII-positive and negative natural killer cells. J Immunol 1989, 143:3183-3191.
10. Alter G, Teigen N, Davis BT, Addo MM, Suscovich TJ, Waring MT, et al: Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection. Blood 2005, 106:3366-3369.
11. Gonzalez VD, Falconer K, Michaelsson J, Moll M, Reichard O, Alaeus A, et al: Expansion of CD56- NK cells in chronic HCV/HIV-1 co-infection: reversion by antiviral treatment with pegylated IFNalpha and ribavirin. Clin Immunol 2008, 128:46-56.
12. Hong HS, Eberhard JM, Keudel P, Bollmann BA, Ahmad F, Ballmaier M, et al: Phenotypically and functionally distinct subsets contribute to the expansion of CD56-/CD16+ natural killer cells in HIV infection. AIDS 2010, 24:1823-1834.
13. Meier UC, Owen RE, Taylor E, Worth A, Naoumov N, Willberg C, et al: Shared alterations in NK cell frequency, phenotype, and function in chronic human immunodeficiency virus and hepatitis C virus infections. J Virol 2005, 79(19):12365-12374.
14. Mantegani P, Tambussi G, Galli L, Din CT, Lazzarin A, Fortis C: Perturbation of the natural killer cell compartment during primary human immunodeficiency virus 1 infection primarily involving the CD56 bright subset. Immunology 2010, 129:220-233.
15. Fogli M, Costa P, Murdaca G, Setti M, Mingari MC, Moretta L, et al: Significant NK cell activation associated with decreased cytolytic function in peripheral blood of HIV-1-infected patients. Eur J Immunol 2004, 34:2313-2321.
16. Ironson G, Balbin E, Solomon G, Fahey J, Klimas N, Schneiderman N, et al: Relative preservation of natural killer cell cytotoxicity and number in healthy AIDS patients with low CD4 cell counts. AIDS 2001, 15:2065-2073.
17. Cooper MA, Fehniger TA, Caligiuri MA: The biology of human natural killer-cell subsets. Trends Immunol 2001, 22:633-640.
18. Parrish-Novak J, Dillon SR, Nelson A, Hammond A, Sprecher C, Gross JA, et al: Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 2000, 408:57-63.
19. Vieillard V, Strominger JL, Debre P: NK cytotoxicity against CD4+ T cells during HIV-1 infection: a gp41 peptide induces the expression of an NKp44 ligand. Proc Natl Acad Sci U S A 2005, 102:10981-10986.
20. Freud AG, Becknell B, Roychowdhury S, Mao HC, Ferketich AK, Nuovo GJ, et al: A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells. Immunity 2005, 22:295-304.
21. Smith BA, Gartner S, Liu Y, Perelson AS, Stilianakis NI, Keele BF, et al: Persistence of infectious HIV on follicular dendritic cells. J Immunol 2001, 166:690-696.
22. Zhang R, Xu J, Hong K, Yuan L, Peng H, Tang H, et al: Increased NKG2A found in cytotoxic natural killer subset in HIV-1 patients with advanced clinical status. AIDS 2007, 21:S9-S17.
23. Mavilio D, Benjamin J, Daucher M, Lombardo G, Kottilil S, Planta MA, et al: Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates. Proc Natl Acad Sci U S A 2003, 100:15011-15016.
24. Mavilio D, Lombardo G, Benjamin J, Kim D, Follman D, Marcenaro E, et al: Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals. Proc Natl Acad Sci U S A 2005, 102:2886-2891.
25. Tagliaferri A, Di Perna C, Santoro C, Schinco P, Santoro R, Rossetti G, et al: Cancers in Patients with Hemophilia: a Retrospective Study from the Italian Association of Hemophilia Centers. J Thromb Haemost 2012, 10:90-95.
26. Bica I, McGovern B, Dhar R, Stone D, McGowan K, Scheib R, et al: Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis 2001, 32:492-497.
27. Greub G, Ledergerber B, Battegay M, Grob P, Perrin L, Furrer H, et al: Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet 2000, 356:1800-1805.
28. Piroth L, Duong M, Quantin C, Abrahamowicz M, Michardiere R, Aho LS, et al: Does hepatitis C virus co-infection accelerate clinical and immunological evolution of HIV-infected patients? AIDS 1998, 12:381-388.
29. Daar ES, Lynn H, Donfield S, Gomperts E, O'Brien SJ, Hilgartner MW, et al: Hepatitis C virus load is associated with human immunodeficiency virus type 1 disease progression in hemophiliacs. J Infect Dis 2001, 183:589-595.
30. Piroth L, Grappin M, Cuzin L, Mouton Y, Bouchard O, Raffi F, et al: Hepatitis C virus co-infection is a negative prognostic factor for clinical evolution in human immunodeficiency virus-positive patients. J Viral Hepat 2000, 7:302-308.
31. Braitstein P, Palepu A, Dieterich D, Benhamou Y, Montaner JS: Special considerations in the initiation and management of antiretroviral therapy in individuals coinfected with HIV and hepatitis C. AIDS 2004, 18:2221-2234.
32. Gupta N, Arthos J, Khazanie P, Steenbeke TD, Censoplano NM, Chung EA, et al: Targeted lysis of HIV-infected cells by natural killer cells armed and triggered by a recombinant immunoglobulin fusion protein: implications for immunotherapy. Virology 2005, 332:491-497.